N-Acetylcysteine in the treatment of steroid-resistant acute graft- versus-host-disease: Preliminary results

Transplantation

Volumn 68, Issue 9, 1999, Pages 1414-1416

  Colombo, Anna A ^a,b   Alessandrino, Emilio P ^b   Bernasconi, Paolo ^b   Arcese, Giorgio W ^c   Rabusin, Marco ^d   Bacigalupo, Andrea ^e   Bernasconi, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

EID: 0033570898     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199911150-00031     Document Type: Article

References (10)

1. Ferrara JLM, Deeg JH. Mechanisms of disease: graft versus host disease. N Engl J Med 1991; 324: 667.
2. Krenger W, Hill GR, Ferrara JLM. Cytokine cascades in acute graft versus host disease. Transplantation 1997; 64: 553.
3. Via CS, Rus V, Nguyen P, Linsley P, Gause WC. Differential effect of CTLA4-Ig on murine graft-versus-host disease (GVHD) development. J Immunol 1996; 157: 4258.
4. Saito K, Yagita H, Hashimoto H, et al. Effect of CD80 and CD86 blockade and anti-interleukin-12 treatment on mouse acute graft-versus-host-disease. Eur J Immunol 1996; 26: 3098.
5. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994; 12: 141.
6. Colombo AA, Ranheim EA, Fong T, Kipps TJ. CD40 signaling in B cells involves reactive oxygen intermediates and induces activation of NF-κB [abstract 2029]. Blood 1994; 84 (suppl 1): 511.
7. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572.
8. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825.
9. Martin PJ, Schoch G, Fisher L, et al. A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. Blood 1991; 77: 1821.
10. Heslop H, Benaim E, Brenner MK, et al. Response of steroid-resistant graft-versus host disease to lymphoblast antibody CBL1. Lancet 1995; 346: 805.